Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Nov 13, 2014

30071_dirs_2014-11-13_6fb8fed6-7500-4985-82ab-6a90fbacba64.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-11-11

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-11 ResMed Common Stock F 2796 $51.15 Disposed 141321 Direct
2014-11-11 ResMed Common Stock F 5964 $51.15 Disposed 135357 Direct
2014-11-11 ResMed Common Stock F 3006 $51.15 Disposed 132351 Direct
2014-11-11 ResMed Common Stock F 3525 $51.15 Disposed 128826 Direct
2014-11-11 ResMed Common Stock F 6470 $51.15 Disposed 122356 Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 11/11/2010 and vesting on 11/11/2014.

F2: Includes 270.197 shares purchased on October 31, 2014, through the company's Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 11/16/2011 and vesting on 11/11/2014.

F4: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 11/15/2012 and vesting on 11/11/2014.

F5: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 3/1/2013 and vesting on 11/11/2014.

F6: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 11/13/2013 and vesting on 11/11/2014.